Pathology News and Research

RSS

Pathology is the study and diagnosis of disease through examination of organs, tissues, bodily fluids, and whole bodies (autopsies). The term also encompasses the related scientific study of disease processes, called General pathology. Medical pathology is divided in two main branches, Anatomical pathology and Clinical pathology. Veterinary pathology is concerned with animal disease whereas Phytopathology is the study of plant diseases.

Studies show evidence-guided molecular profiling improves treatment for hard-to-treat cancers

Caris Life Sciences announced today data from two studies presented at the 2013 European Cancer Congress, which demonstrate the potential of evidence-guided molecular profiling to immediately improve the treatment of patients with hard-to-treat cancers, including cancers of unknown primary (CUP) origins as well as rare tumors and cancers that have been refractory to treatment.

29 Sep 2013

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

The prevalence of skin disease exceeds that of obesity, hypertension or cancer. One in three individuals in the United States suffers with a skin disease, with ~2-3% of the American population suffering from psoriasis.

27 Sep 2013

College of American Pathologists awards accreditation to Ameritox

Ameritox has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) for a second time, based on the results of recent onsite inspections of its laboratories.

27 Sep 2013

Length of telomere may help determine prostate cancer patient's prognosis

Like the plastic caps at the end of shoelaces, telomeres protect — in their case — the interior-gene containing parts of chromosomes that carry a cell's instructional material. Cancer cells are known to have short telomeres, but just how short they are from cancer cell to cancer cell may be a determining factor in a prostate cancer patient's prognosis, according to a study led by Johns Hopkins scientists.

27 Sep 2013

Genomic instability in CFS is associated with less favorable outcome in patients with CaP

Detailed evaluation of a prostate cancer tumor biopsy may predict treatment outcomes for image-guided radiation therapy (IGRT) or surgery for prostate cancer, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

27 Sep 2013

Genes in mitochondria shape each person's risk for heart disease and diabetes

Genes in mitochondria, the "powerhouses" that turn sugar into energy in human cells, shape each person's risk for heart disease and diabetes, according to a study published recently by researchers at the University of Alabama at Birmingham in the Biochemical Journal.

27 Sep 2013

Intestinal mucus potentially improves life of people suffering from inflammatory bowel disease

Researchers at Institut Hospital del Mar d'Investigacions M-diques (IMIM) in Barcelona, in collaboration with the Icahn School of Medicine at Mount Sinai in New York and other U.S. Institutions, have found that intestinal mucus not only acts as a physical barrier against commensal bacteria and dietary antigens, but also prevents the onset of inflammatory reactions against these agents.

27 Sep 2013

New ultra-specific test now available for prostate cancer

A new urine test for prostate cancer that measures minute fragments of RNA is now commercially available to men nationwide through the University of Michigan MLabs.

27 Sep 2013

University of Michigan offers new test to improve PSA screening for prostate cancer

More than 1 million men will undergo a prostate biopsy this year, but only about one-fifth of those biopsies will result in a cancer diagnosis.

26 Sep 2013

MGH researchers identify rare gene mutations that appear to cause late-onset AD

Massachusetts General Hospital (MGH) researchers have identified and validated two rare gene mutations that appear to cause the common form of Alzheimer's disease (AD) that strikes after the age of 60.

25 Sep 2013

University of Texas MD Anderson Cancer Center receives $48.6M grant from NCI

Broad, deep and outstanding research in cancer science, treatment and prevention have earned The University of Texas MD Anderson Cancer Center a $48.6-million, five-year grant from the National Cancer Institute and an "exceptional" ranking, the highest possible, from the NCI's extensive peer-review process.

25 Sep 2013

Changes due to single mild explosion in brain has similarity with Alzheimer's

A new study published in the September issue of the Journal of Alzheimer's Disease reports that even a single mild explosion can cause changes in the brain that have similarities to those found in diseases like Alzheimer's disease and chronic traumatic encephalopathy.

25 Sep 2013

First Direct Measurement Of Spinal Cord Myelin In MS

...

24 Sep 2013

Escapism, social interaction and rewards fuel problematic gaming behaviors among adults

New research from the University of Missouri indicates escapism, social interaction and rewards fuel problematic video-game use among "very casual" to "hardcore" adult gamers. Understanding individual motives that contribute to unhealthy game play could help counselors identify and treat individuals addicted to video games.

24 Sep 2013

Researchers develop first imaging tool to examine myelin damage in MS

Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.

24 Sep 2013

Scientists validate new system for identifying individuals with preclinical Alzheimer's disease

For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can last a decade or more before symptoms appear, is the critical phase when the disease might be controlled or stopped, possibly preventing the failure of memory and thinking abilities in the first place.

24 Sep 2013

UNC receives grants from FDA and NIH to establish Tobacco Centers of Regulatory Science

The University of North Carolina at Chapel Hill received two separate grants from the U.S. Food and Drug Administration and the National Institutes of Health today as part of an on-going interagency partnership. UNC will house two of 14 Tobacco Centers of Regulatory Science, which are receiving a total of up to $53 million for tobacco-related research in fiscal year 2013.

21 Sep 2013

Pathology News and Research

Further Reading

Studies show evidence-guided molecular profiling improves treatment for hard-to-treat cancers

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

College of American Pathologists awards accreditation to Ameritox

Length of telomere may help determine prostate cancer patient's prognosis

Genomic instability in CFS is associated with less favorable outcome in patients with CaP

Genes in mitochondria shape each person's risk for heart disease and diabetes

Intestinal mucus potentially improves life of people suffering from inflammatory bowel disease

New ultra-specific test now available for prostate cancer

University of Michigan offers new test to improve PSA screening for prostate cancer

MGH researchers identify rare gene mutations that appear to cause late-onset AD

University of Texas MD Anderson Cancer Center receives $48.6M grant from NCI

Changes due to single mild explosion in brain has similarity with Alzheimer's

First Direct Measurement Of Spinal Cord Myelin In MS

Escapism, social interaction and rewards fuel problematic gaming behaviors among adults

Researchers develop first imaging tool to examine myelin damage in MS

Scientists validate new system for identifying individuals with preclinical Alzheimer's disease

UNC receives grants from FDA and NIH to establish Tobacco Centers of Regulatory Science

New cellular switch could eventually inhibit growth of aggressive malignant brain tumor

Visual clue to schizophrenia pathology

Ventana, Boehringer Ingelheim to develop companion diagnostic tests for oncology programs

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News